StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
3SBio Inc.
HKSE:1530.HK
Sector
Location
Market Cap
USD 8.61 B
Share Price
USD 3.67
Avg Daily Volume
55,226,032
Change (1 day)
-5.23%
Change (1 year)
362.16%
Change (YTD)
369.01%
3SBio Inc. Operating Cash Flow for the year ending December 31, 2024: USD 438.44 M
3SBio Inc. Operating Cash Flow is USD 438.44 M for the year ending December 31, 2024, a 49.45% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
3SBio Inc. Operating Cash Flow for the year ending December 31, 2023 was USD 293.37 M, a -7.14% change year over year.
-
3SBio Inc. Operating Cash Flow for the year ending December 31, 2022 was USD 315.94 M, a 27.19% change year over year.
-
3SBio Inc. Operating Cash Flow for the year ending December 31, 2021 was USD 248.40 M, a 20.59% change year over year.
-
3SBio Inc. Operating Cash Flow for the year ending December 31, 2020 was USD 205.99 M, a -24.00% change year over year.
Competitors
AbbVie Inc.
USD 190.83
ABBV
+0.28
0.15%
Novo Nordisk A/S
USD 70.34
NOVO-B.CO
+0.69
0.98%
Roche Holding AG
USD 352.25
RO.SW
+3.41
0.98%
Novartis AG
USD 117.50
NOVN.SW
+0.23
0.19%
AstraZeneca PLC
USD 147.28
AZN.L
+2.35
1.62%
Abbott Laboratories
USD 125.64
ABT
-0.19
-0.15%
Merck & Co., Inc.
USD 84.11
MRK
+0.13
0.15%
Amgen Inc.
USD 308.55
AMGN
-0.67
-0.22%
Pfizer Inc.
USD 25.35
PFE
-0.01
-0.04%
Gilead Sciences, Inc.
USD 113.20
GILD
-0.36
-0.32%
Vertex Pharmaceuticals Incorporated
USD 472.27
VRTX
-4.68
-0.98%
Sanofi
USD 100.09
SAN.PA
+0.48
0.48%
Bristol-Myers Squibb Company
USD 48.94
BMY
-0.04
-0.08%
CSL Limited
USD 177.62
CSL.AX
+2.36
1.34%
Chugai Pharmaceutical Co., Ltd.
USD 49.80
4519.T
+0.60
1.22%
GSK plc
USD 18.78
GSK.L
+0.16
0.83%
Regeneron Pharmaceuticals, Inc.
USD 564.64
REGN
-7.75
-1.35%
MERCK Kommanditgesellschaft auf Aktien
USD 133.12
MRK.DE
+0.98
0.74%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.04
600276.SS
+0.06
0.73%
Takeda Pharmaceutical Company Limited
USD 29.42
4502.T
-0.15
-0.50%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
AbbVie Inc.
USD 190.83
ABBV
+0.28
0.15%
Novo Nordisk A/S
USD 70.34
NOVO-B.CO
+0.69
0.98%
Roche Holding AG
USD 352.25
RO.SW
+3.41
0.98%
Novartis AG
USD 117.50
NOVN.SW
+0.23
0.19%
AstraZeneca PLC
USD 147.28
AZN.L
+2.35
1.62%
Abbott Laboratories
USD 125.64
ABT
-0.19
-0.15%
Merck & Co., Inc.
USD 84.11
MRK
+0.13
0.15%
Amgen Inc.
USD 308.55
AMGN
-0.67
-0.22%
Pfizer Inc.
USD 25.35
PFE
-0.01
-0.04%
Gilead Sciences, Inc.
USD 113.20
GILD
-0.36
-0.32%
Vertex Pharmaceuticals Incorporated
USD 472.27
VRTX
-4.68
-0.98%
Sanofi
USD 100.09
SAN.PA
+0.48
0.48%
Bristol-Myers Squibb Company
USD 48.94
BMY
-0.04
-0.08%
CSL Limited
USD 177.62
CSL.AX
+2.36
1.34%
Chugai Pharmaceutical Co., Ltd.
USD 49.80
4519.T
+0.60
1.22%
GSK plc
USD 18.78
GSK.L
+0.16
0.83%
Regeneron Pharmaceuticals, Inc.
USD 564.64
REGN
-7.75
-1.35%
MERCK Kommanditgesellschaft auf Aktien
USD 133.12
MRK.DE
+0.98
0.74%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.04
600276.SS
+0.06
0.73%
Takeda Pharmaceutical Company Limited
USD 29.42
4502.T
-0.15
-0.50%